All Photos(3)
Synonym(s):
Ethyl eicosanoate, Ethyl ester of eicosanoic acid, Arachidic acid ethyl ester
Empirical Formula (Hill Notation):
C22H44O2
CAS Number:
Molecular Weight:
340.58
MDL number:
UNSPSC Code:
12352211
PubChem Substance ID:
NACRES:
NA.25
Recommended Products
biological source
synthetic (organic)
Quality Level
Assay
≥99%
form
solid
functional group
ester
lipid type
omega FAs
shipped in
ambient
storage temp.
−20°C
SMILES string
CCCCCCCCCCCCCCCCCCCC(=O)OCC
InChI
1S/C22H44O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24-4-2/h3-21H2,1-2H3
InChI key
YBKSMWBLSBAFBQ-UHFFFAOYSA-N
Application
- Optimizing the Design of Blood-Brain Barrier-Penetrating Polymer-Lipid-Hybrid Nanoparticles for Delivering Anticancer Drugs to Glioblastoma.: This study explores the development of nanoparticles that can cross the blood-brain barrier to deliver anticancer drugs directly to glioblastoma, utilizing ethyl arachidate in their composition to enhance drug encapsulation and targeting (Ahmed et al., 2021).
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Samara R Alves Rico et al.
Nanoscale, 9(30), 10701-10714 (2017-07-06)
A unique class of diruthenium(ii,iii) metallodrugs containing non-steroidal anti-inflammatory drug (NSAID), Ru
Samara Rodrigues Alves et al.
Journal of inorganic biochemistry, 205, 110984-110984 (2020-01-14)
Novel formulations of diruthenium(II,III)-NSAID (NSAID, non-steroidal anti-inflammatory drug) metallodrugs encapsulated into biocompatible terpolymer-lipid nanoparticles (TPLNs) to target glioblastoma cancer were developed. The nanoformulations of Ibuprofenate (RuIbp) and Naproxenate (RuNpx) metallodrugs were synthesized and characterized. The procedure rationally designed to avoid
Tian Zhang et al.
Advanced healthcare materials, 8(18), e1900543-e1900543 (2019-07-28)
Patients with brain metastases of triple negative breast cancer (TNBC) have a poor prognosis owing to the lack of targeted therapies, the aggressive nature of TNBC, and the presence of the blood-brain barrier (BBB) that blocks penetration of most drugs.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service